Chronic Myelomonocytic Leukemia Completed Phase 1 Trials for Clofarabine (DB00631)

Also known as: Chronic myelomonocytic leukaemia / Chronic myelomonocytic leukemia with failed remission / Leukemia, Myelomonocytic, Chronic

IndicationStatusPhase
DBCOND0028572 (Chronic Myelomonocytic Leukemia)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01629082Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid LeukemiaTreatment